Serum soluble CD25, Galectin-9, and CXCL9 as immunological markers differentiating complete remission from refractory acute myeloid leukemia

Abdullah Salim Al-Karawi, Ali Saad Al-Budairi, Ali M. Atoom
Clinical Immunology · Elsevier · DOI: 10.1016/j.clim.2026.110750

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles